Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
F11 encodes coagulation factor XI of the blood coagulation cascade. Additionally we are shipping Factor XI Kits (48) and Factor XI Proteins (16) and many more products for this protein.
Showing 10 out of 86 products:
High molecular weight kininogen has an inhibitory effect on nucleic acid-supported fXI activation and may function as a negative regulator of fXI activation.
FXI has a role in promoting a vascular coagulation-inflammatory circuit in arterial hypertension
thrombin activatable fibrinolysis inhibitor (show CPB2 Antibodies) pathway impairment, largely caused by a hitherto unknown TAFIa resistance, appears to be one main cause of decreased fibrinolytic resistance in FXI deficiency
Three loci showed robust, replicating association with circulating FXI levels: KNG1 (show KNG1 Antibodies) (rs710446, P-value = 2.07 x 10-302), F11 (rs4253417, P-value = 2.86 x 10-193), and a novel association in GCKR (show GCKR Antibodies) (rs780094, P-value = 3.56 x10-09), here for the first time implicated in FXI regulation. The two first SNPs (rs710446 and rs4253417) also associated with partial thromboplastin (show F3 Antibodies) time
The rs710446 and five low-frequency variant sets in KNG1 (show KNG1 Antibodies) with FXI level variation of Factor XI were significant after multiple testing correction and permutation.
Exploring the global landscape of genetic variation in coagulation factor XI deficiency
Structures of FXI in complex with the laminin-derived peptide EFPDFP and a DFP (show PPCS Antibodies) peptide from the random screen demonstrated binding in the same pocket, although in a slightly different conformation, thus revealing some flexibility in the molecular interactions of the FXI apple 2 domain.
inhibition of FXI and FXII (show F12 Antibodies) distinctly alter the biophysical properties of fibrin.
Acute Coronary Syndrome patients had an enhanced prothrombotic profile, demonstrated by an increased thrombin (show F2 Antibodies) generation potential, factor XIa and D-dimer levels.
Data show that among the studied polymorphisms, only coagulation factor XI (F11) single nucleotide polymorphism rs2289252 was significantly associated with venous thrombosis (VT) and the F11 rs2289252-A allele was associated with a 1.6-fold increased risk of VT
FXI attenuates part of the allergic response to repeated administration of house dust mite in the airways by a mechanism that is independent of activation via FXII (show F12 Antibodies).
Thrombin (show F2 Antibodies)-independent contribution of tissue factor (show F3 Antibodies) to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease.
FXI deprivation was shown to slow down atherogenesis in Apoe (show APOE Antibodies) knockout mice.
anion-binding sites on FXIa that are required for expression of heparin's cofactor activity during protease inhibition by antithrombin (show SERPINC1 Antibodies) are also required for expression of polyP cofactor activity during FXI activation
Data conclude that within the mouse F11, Klkb1 (show KLKB1 Antibodies), Cyp4v3 (show CYP4V2 Antibodies) gene cluster, F11 and Cyp4v3 (show CYP4V2 Antibodies) frequently display striking parallel transcriptional responses suggesting the presence of shared regulatory elements.
Studies indicate that targeting factor XI (FXI) by knocking out the gene prevents arterial and vein thrombosis.
Protective roles for fibrin, tissue factor (show F3 Antibodies), plasminogen activator inhibitor-1 (show SERPINE1 Antibodies), and thrombin activatable fibrinolysis inhibitor (show CPB2 Antibodies), but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica.
fXI and fXII (show F12 Antibodies) contribute to thrombus formation even when factor VIIa/tissue factor (show F3 Antibodies) initiates thrombosis.
Gene targeting of tissue factor (show F3 Antibodies), factor X, and factor VII (show TH Antibodies) in mice: their involvement in embryonic development
FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse.
Sequence analysis of the bovine coagulation factor XI (F11) gene revealed an unusually high number of non-synonymous mutations. However, none of the mutations in the F11 gene were concordant with Bovine neonatal pancytopenia status.
Insertion of 15 nucleotides in the F11 gene is the causative mutation for factor XI deficiency in Japanese black cattle.
The molecular basis of coagulopathy has been recognized in Holstein cattle as a 76-bp insertion in the coding region of the FXI gene
This gene encodes coagulation factor XI of the blood coagulation cascade. This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodimer consisting of two identical polypeptide chains linked by disulfide bonds. During activation of the plasma factor XI, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in activated factor XIa, a serine protease composed of two heavy and two light chains held together by disulfide bonds. This activated plasma factor XI triggers the middle phase of the intrisic pathway of blood coagulation by activating factor IX. Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality.
, plasma thromboplastin antecedent
, coagulation factor XI (plasma thromboplastin antecedent)
, factor XI
, platelet coagulation factor XI
, blood coagulation factor XI
, coagulation factor XI
, coagulation factor XI-like